-+ 0.00%
-+ 0.00%
-+ 0.00%

Mapletree Industrial Trust (SGX:ME8U) Q2 Results Reveal DPU Pressure And Vacancy Drag

Simply Wall St·10/28/2026 11:38:34
Listen to the news

Mapletree Industrial Trust walked into this Q2 FY2027 release with units at SGD1.74, flat over 7 days yet down over the past quarter, and sentiment already bruised by softer margins and a chunky one off loss in the last 12 months. The headline this time is distribution per unit pressure, with the latest quarter payout described as lower year on year and quarter on quarter as borrowing costs bite and North America vacancies drag.

The market reaction now hinges on whether that weaker distribution stream justifies the recent price drift or reflects investors leaning too hard into fear about funding costs and US exposure.

Like the yield story on Mapletree Industrial Trust but uneasy about payout pressure and funding costs creeping higher? Look at our screener of stronger balance sheet and fundamentals ideas through the list of solid balance sheet and fundamentals stocks (207 results).

Q2 2027 Earnings Summary

  • Revenue (Q2 2027 vs Q2 2026): S$167.0m vs. S$177.2m (down about 5.8%)
  • Net Income, Excl. Extra Items (Q2 2027 vs Q2 2026): S$83.0m vs. S$88.2m (down about 5.9%)
  • Basic EPS, Earnings per Unit, EPU (Q2 2027 vs Q2 2026): S$0.0282 vs. S$0.0309 (down about 8.7%)
  • Trailing 12 Month Net Income, Excl. Extra Items (Q2 2027 TTM vs Q2 2026 TTM): S$193.4m vs. S$331.4m (down about 41.6%)

Earnings tell part of the story, but investors who care about what they are really paying for usually follow the cash flowing through Mapletree Industrial Trust.

Based on Mapletree Industrial Trust's cash flows alone, the stock could be a slight 13% undervalued.

SGX:ME8U Trailing 12-Month Earnings & Revenue History as at Oct 2026
SGX:ME8U Trailing 12-Month Earnings & Revenue History as at Oct 2026

Mapletree Industrial Trust’s Recycling Plan Faces Early Friction

The bullish pitch rests on Mapletree Industrial Trust turning asset sales into steadier, long lease data centre income.

"The main thing that has to go right is successful recycling of roughly S$500 to S$600 million of largely vacant or structurally challenged North American and Singapore assets into more resilient data centre properties while keeping leverage and funding costs under control."

On that score, progress is mixed. Management has only closed a small U.S. divestment, with the S$500 to S$600 million programme still largely a target. DPU is under pressure and average funding cost has moved to about 3.3% and is guided higher, so the balance sheet is not yet clearly benefiting from this recycling ambition.

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all.

Evaluating MIT’s Bear Case On Vacancies And DPU

The bearish view focuses on North American vacancies and non renewals, which are seen as gradually pushing distributions lower while leasing wins come through more slowly.

"Bearish analysts expect Mapletree Industrial Trust to see ongoing pressure on occupancy and rental income, with US data centre vacancies and non renewals weighing on earnings even as new leases are signed."

The latest quarter reflects some of these concerns. Mapletree Industrial Trust’s portfolio occupancy eased to 89.7%, US data centre occupancy slipped to 79.1%, and DPU declined 6.6% year on year. Fresh leases in Alpharetta and San Jose support future income, but rent free periods and lower signing rates mean they do not yet offset the drag in this set of results.

Hunt For Mispriced Cash Flows

Mapletree Industrial Trust recently highlighted how funding costs and vacancies can affect reported income. The real opportunity sits in assessing stocks that could be undervalued before the market closes that gap.

  • Company 1 - 48% below our estimate - converts copper, optical and high power harness capabilities into projects serving AI data centers and semiconductor customers.
  • Company 2 - 23% below our estimate - expands a surgical robotics platform from knee procedures into shoulder and complex joint applications to deepen use in hospitals.
  • Company 3 - 25% below our estimate - shifts a probiotic portfolio toward faster growing adult and oral health products distributed through direct and partner channels.

That is three of the list. See all 195 potentially undervalued companies →